Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1981 Jul;45(1):205–214.

Spontaneous and antibody-dependent cellular cytotoxicity by lymphocyte subpopulations in peripheral blood and spleen from adult untreated patients with Hodgkin's disease.

S Gupta, G Fernandes
PMCID: PMC1537263  PMID: 6975681

Abstract

Subpopulations of lymphocytes in the peripheral blood and spleen from adult untreated patients with Hodgkin's disease were studied for spontaneous (SCMC) and antibody-dependent cellular cytotoxicities (ADCC). Peripheral blood from seven of 24 patients demonstrated abnormally low T cell-mediated SCMC when compared to age- and sex-matched healthy controls. Only two of these patients also demonstrated low T cell ADCC and non-T cell-mediated SCMC and ADCC. T cell ADCC in the peripheral blood of patients with involved spleen was significantly higher (P less than 0.05) when compared to those in whom spleen was not involved. When SCMC and ADCC were compared between peripheral blood and splenic lymphocytes with regard to involvement of spleen by Hodgkin's disease, non-T cell SCMC in the involved spleen was significantly lower (P less than 0.05) than their peripheral blood non-T cell SCMC. SCMC and ADCC tended to be higher in patients with stages III and IV of Hodgkin's disease when compared to those with stages I and II. However, the differences were not statistically significant. No direct relationship was observed between T and SCMC or ADCC and the proportion of T cells with IgG Fc receptors (T gamma). The significance of these observations is discussed.

Full text

PDF
205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AISENBERG A. C. Studies on delayed hypersensitivity in Hodgkin's disease. J Clin Invest. 1962 Nov;41:1964–1970. doi: 10.1172/JCI104654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amlot P. L., Pussell B., Slaney J. M., Williams B. D. Correlation between immune complexes and prognostic factors in Hodgkin's disease. Clin Exp Immunol. 1978 Feb;31(2):166–173. [PMC free article] [PubMed] [Google Scholar]
  3. Björkholm M., Holm G., Mellstedt H., Johansson B., Killander D., Sunblad R., Söderberg G. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect. Scand J Haematol. 1978 Apr;20(4):306–318. [PubMed] [Google Scholar]
  4. Bobrove A. M., Fuks Z., Strober S., Kaplan H. S. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease. Cancer. 1975 Jul;36(1):169–179. doi: 10.1002/1097-0142(197507)36:1<169::aid-cncr2820360115>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  5. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  6. Case D. C., Jr, Hansen J. A., Corrales E., Young C. W., Dupont B., Pinsky C. M., Good R. A. Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin disease in continuous long remissions. Blood. 1977 May;49(5):771–778. [PubMed] [Google Scholar]
  7. Djeu J. Y., Heinbaugh J. A., Holden H. T., Herberman R. B. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol. 1979 Jan;122(1):175–181. [PubMed] [Google Scholar]
  8. Eltringham J. R., Kaplan H. S. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease. Natl Cancer Inst Monogr. 1973 May;36:107–115. [PubMed] [Google Scholar]
  9. Fuks Z., Strober S., Kaplan H. S. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test. N Engl J Med. 1976 Dec 2;295(23):1273–1278. doi: 10.1056/NEJM197612022952301. [DOI] [PubMed] [Google Scholar]
  10. Goodwin J. S., Messner R. P., Bankhurst A. D., Peake G. T., Saiki J. H., Williams R. C., Jr Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977 Nov 3;297(18):963–968. doi: 10.1056/NEJM197711032971802. [DOI] [PubMed] [Google Scholar]
  11. Gupta S., Fernandes G., Nair M., Good R. A. Spontaneous and antibody-dependent cell-mediated cytotoxicity by human T cell subpopulations. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5137–5141. doi: 10.1073/pnas.75.10.5137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gupta S., Good R. A. Markers of human lymphocyte subpopulations in primary immunodeficiency and lymphoproliferative disorders. Semin Hematol. 1980 Jan;17(1):1–29. [PubMed] [Google Scholar]
  13. Gupta S., Good R. A. Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids, and irradiation. Cell Immunol. 1977 Nov;34(1):10–18. doi: 10.1016/0008-8749(77)90224-6. [DOI] [PubMed] [Google Scholar]
  14. Gupta S. Subpopulations of human T lymphocytes. XVI. Maldistribution of T cell subsets associated with abnormal locomotion of T cells in untreated adult patients with Hodgkin's disease. Clin Exp Immunol. 1980 Oct;42(1):186–195. [PMC free article] [PubMed] [Google Scholar]
  15. Gupta S., Tan C. Subpopulations of human T lymphocytes. XIV. Abnormality of T-cell locomotion and of distribution of subpopulations of T and B lymphocytes in peripheral blood and spleen from children with untreated Hodgkin's disease. Clin Immunol Immunopathol. 1980 Feb;15(2):133–143. doi: 10.1016/0090-1229(80)90026-4. [DOI] [PubMed] [Google Scholar]
  16. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  17. Herberman R. B., Nunn M. E., Holden H. T., Lavrin D. H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer. 1975 Aug 15;16(2):230–239. doi: 10.1002/ijc.2910160205. [DOI] [PubMed] [Google Scholar]
  18. Hersh E. M., Oppenheim J. J. Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med. 1965 Nov 4;273(19):1006–1012. doi: 10.1056/NEJM196511042731903. [DOI] [PubMed] [Google Scholar]
  19. Hillinger S. M., Herzig G. P. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. J Clin Invest. 1978 Jun;61(6):1620–1627. doi: 10.1172/JCI109082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Holm G., Angelin B., Björkholm M., Ericsson P., Mellstedt H., Pettersson D. Immunosuppressive serum factors and lymphocyte deficiency in Hodgkin's disease. J Clin Lab Immunol. 1979 Feb;1(4):269–275. [PubMed] [Google Scholar]
  21. Holm G., Mellstedt H., Björkholm M., Johansson B., Killander D., Sundblad R., Söderberg G. Lymphocyte abnormalities in untreated patients with Hodgkin's disease. Cancer. 1976 Feb;37(2):751–762. doi: 10.1002/1097-0142(197602)37:2<751::aid-cncr2820370223>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  22. KELLY W. D., LAMB D. L., VARCO R. L., GOOD R. A. An investigation of Hodgkin's disease with respect to the problem of homotransplantation. Ann N Y Acad Sci. 1960 May 31;87:187–202. doi: 10.1111/j.1749-6632.1960.tb23192.x. [DOI] [PubMed] [Google Scholar]
  23. Kall M. A., Koren H. S. Heterogeneity of human natural killer cell populations. Cell Immunol. 1978 Sep 15;40(1):58–68. doi: 10.1016/0008-8749(78)90315-5. [DOI] [PubMed] [Google Scholar]
  24. Kay H. D., Bonnard G. D., West W. H., Herberman R. B. A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol. 1977 Jun;118(6):2058–2066. [PubMed] [Google Scholar]
  25. Kiessling R., Haller O. Natural killer cells in the mouse: an alternative immune surveillance mechanism? Contemp Top Immunobiol. 1978;8:171–201. doi: 10.1007/978-1-4684-0922-2_6. [DOI] [PubMed] [Google Scholar]
  26. Kiessling R., Petranyi G., Kärre K., Jondal M., Tracey D., Wigzell H. Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems. J Exp Med. 1976 Apr 1;143(4):772–780. doi: 10.1084/jem.143.4.772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kohl S., Pickering L. K., Sullivan M. P., Walters D. L. Impaired monocyte-macrophage cytotoxicity in patients with Hodgkin's disease. Clin Immunol Immunopathol. 1980 Apr;15(4):577–585. doi: 10.1016/0090-1229(80)90001-x. [DOI] [PubMed] [Google Scholar]
  28. Koren H. S., Williams M. S. Natural killing and antibody-dependent cellular cytotoxicity are mediated by different mechanisms and by different cells. J Immunol. 1978 Nov;121(5):1956–1960. [PubMed] [Google Scholar]
  29. Levy R., Kaplan H. S. Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med. 1974 Jan 24;290(4):181–186. doi: 10.1056/NEJM197401242900402. [DOI] [PubMed] [Google Scholar]
  30. Long J. C., Hall C. L., Brown C. A., Stamatos C., Weitzman S. A., Carey K. Binding of soluble immune complexes in serum of patients with Hodgkin's disease to tissue cultures derived from the tumor. N Engl J Med. 1977 Aug 11;297(6):295–299. doi: 10.1056/NEJM197708112970602. [DOI] [PubMed] [Google Scholar]
  31. Moretta L., Webb S. R., Grossi C. E., Lydyard P. M., Cooper M. D. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med. 1977 Jul 1;146(1):184–200. doi: 10.1084/jem.146.1.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Moroz C., Lahat N., Biniaminov M., Ramot B. Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole. Clin Exp Immunol. 1977 Jul;29(1):30–35. [PMC free article] [PubMed] [Google Scholar]
  33. Nair P. N., Fernandes G., Onoe K., Day N. K., Good R. A. Inhibition of effector cell functions in natural killer cell activity (NK) and antibody-dependent cellular cytotoxicity (ADCC) in mice by normal and cancer sera. Int J Cancer. 1980 May 15;25(5):667–677. doi: 10.1002/ijc.2910250518. [DOI] [PubMed] [Google Scholar]
  34. Ojo E., Wigzell H. Natural killer cells may be the only cells in normal mouse lymphoid cell populations endowed with cytolytic ability for antibody-coated tumour target cells. Scand J Immunol. 1978 Apr;7(4):297–306. doi: 10.1111/j.1365-3083.1978.tb00457.x. [DOI] [PubMed] [Google Scholar]
  35. Pehamberger H., Ludwig H., Pötzi P., Knapp W. Increased monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) in Hodgkin's disease. Br J Cancer. 1980 May;41(5):778–781. doi: 10.1038/bjc.1980.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pichler W. J., Gendelman F. W., Nelson D. L. Fc receptors on human T lymphocytes. II. Cytotoxic capabilities of human T gamma, T mu, B, and L cells. Cell Immunol. 1979 Feb;42(2):410–417. doi: 10.1016/0008-8749(79)90206-5. [DOI] [PubMed] [Google Scholar]
  37. Platsoucas C. D., Fernandes G., Gupta S. L., Kempin S., Clarkson B., Good R. A., Gupta S. Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon. J Immunol. 1980 Sep;125(3):1216–1223. [PubMed] [Google Scholar]
  38. Pross H. F., Jondal M. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol. 1975 Aug;21(2):226–235. [PMC free article] [PubMed] [Google Scholar]
  39. Rassiga-Pidot A. L., McIntyre O. R. In vitro leukocyte interferon production in patients with Hodgkin's disease. Cancer Res. 1974 Nov;34(11):2995–3002. [PubMed] [Google Scholar]
  40. Russell A. S., Essery G. Cellular immunity to herpes simplex virus in man. VII. K-cell activity to HSV1 infected target cells in disease. Cancer. 1977 Jul;40(1):42–45. doi: 10.1002/1097-0142(197707)40:1<42::aid-cncr2820400109>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  41. SCHIER W. W., ROTH A., OSTROFF G., SCHRIFT M. H. Hodgkin's disease and immunity. Am J Med. 1956 Jan;20(1):94–99. doi: 10.1016/0002-9343(56)90176-0. [DOI] [PubMed] [Google Scholar]
  42. Schulof R. S., Lee B. J., Lacher M. J., Straus D. J., Clarkson B. D., Good R. A., Gupta S. Concanavalin A-induced suppressor cell activity in Hodgkin's disease. Clin Immunol Immunopathol. 1980 Aug;16(4):454–462. doi: 10.1016/0090-1229(80)90187-7. [DOI] [PubMed] [Google Scholar]
  43. Sibbitt W. L., Jr, Bankhurst A. D., Williams R. C., Jr Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease. J Clin Invest. 1978 Jan;61(1):55–63. doi: 10.1172/JCI108925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Siegal F. P. Inhibition of T-cell rosette formation by Hodgkin-disease serum. N Engl J Med. 1976 Dec 2;295(23):1314–1315. doi: 10.1056/NEJM197612022952310. [DOI] [PubMed] [Google Scholar]
  45. Sousa M. D., Yang M., Lopes-Corrales E., Tan C., Hansen J. A., Dupont B., Good R. A. Ecotaxis: the principle and its application to the study of Hodgkin's disease. Clin Exp Immunol. 1977 Jan;27(1):143–151. [PMC free article] [PubMed] [Google Scholar]
  46. Stevens D. A., Merigan T. C. Interferon, antibody, and other host factors in herpes zoster. J Clin Invest. 1972 May;51(5):1170–1178. doi: 10.1172/JCI106910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Twomey J. J., Laughter A. H., Farrow S., Douglass C. C. Hodgkin's disease. An immunodepleting and immunosuppressive disorder. J Clin Invest. 1975 Aug;56(2):467–475. doi: 10.1172/JCI108113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wisloff F., Froland S. S., Michaelsen T. E. Antibody-dependent cytotoxicity mediated by human Fc-receptor-bearing cells lacking markers for B- and T-lymphocytes. Int Arch Allergy Appl Immunol. 1974;47(1):139–154. doi: 10.1159/000231208. [DOI] [PubMed] [Google Scholar]
  49. Young R. C., Corder M. P., Haynes H. A., DeVita V. T. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med. 1972 Jan;52(1):63–72. doi: 10.1016/0002-9343(72)90008-3. [DOI] [PubMed] [Google Scholar]
  50. de Landazuri M. O., Silva A., Alvarez J., Herberman R. B. Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations. J Immunol. 1979 Jul;123(1):252–258. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES